Last 145,100
Change Today 0.00 / 0.00%
Volume 0.0
MERK On Other Exchanges
As of 4:00 AM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

merck tbk pt (MERK) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/25/14 - $207,000
52 Week Low
02/9/15 - $140,000
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MERCK TBK PT (MERK)

Related News

No related news articles were found.

merck tbk pt (MERK) Related Businessweek News

No Related Businessweek News Found

merck tbk pt (MERK) Details

PT Merck Tbk is engaged in pharmaceutical and chemical businesses in Indonesia. It operates in three segments: Merck Serono, Consumer Health, and Chemical. The company offers prescription drugs of chemical and biotechnological origin for use in the therapeutic areas, such as neurodegenerative diseases, oncology, fertility, endocrinology, and rheumatology; and consumer healthcare products comprising over-the-counter pharmaceuticals for adults, kids, and babies under the Sangobion, Neurobion, Seven Seas, Iliadin, Becombion, and Evion brand names. It also provides performance materials, advanced technologies, and high-tech chemicals to clients in the consumer electronics, lighting, printing, plastics, and cosmetics industries, as well as supplies a range of tools to the life science industry. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is based in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.

657 Employees
Last Reported Date: 10/31/14
Founded in 1970

merck tbk pt (MERK) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

merck tbk pt (MERK) Key Developments

PT Merck Tbk Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2012; Proposes Dividend for 2012

PT Merck Tbk reported earnings results for the fourth quarter and year ended December 31, 2012. For the quarter, total Revenues were EUR 2,834.8 million against EUR 2,625.7 million a year ago. Sales was were EUR 2,712.1 million against EUR 2,524.5 million a year ago. EBITDA pre-one-time items were EUR 789.8 million against EUR 680.6 million a year ago. Net income were EUR 271.8 million or EUR 2.05 per share against EUR 132.9 million or EUR 1.66 per share a year ago. Free cash flow of was EUR 180 million against EUR 56 million a year ago. For the year, total Revenues were EUR 11,172.9 million against EUR 10,276.4 million a year ago. Sales was were EUR 10,740.8 million against EUR 9,905.9 million a year ago. EBITDA pre one-time items were EUR 2,964.9 million against EUR 2,723.8 million a year ago. Net income were EUR 566.7 million or EUR 7.61 per share against EUR 606.5 million or EUR 6.79 per share a year ago. Net financial debt as on December 31, 2012, was EUR 1,925.9 million against EUR 3,484.4 million a year ago. Free cash flow of was EUR 2,040 million against EUR 1,436 million a year ago. For fiscal 2012, the company will propose to the Annual General Meeting on April 26, 2013, that the dividend payment be increased by 20 cents to EUR 1.70 per share, an increase of 13%.

PT Merck Tbk, Annual General Meeting, Apr 26, 2013

PT Merck Tbk, Annual General Meeting, Apr 26, 2013. Agenda: To consider the payment of Dividend.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MERK:IJ 145,100.00 0.00

MERK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MERK.
View Industry Companies

Industry Analysis


Industry Average

Valuation MERK Industry Range
Price/Earnings 18.8x
Price/Sales 2.5x
Price/Book 6.0x
Price/Cash Flow 18.8x
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK TBK PT, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at